Who would have thought that the jujube that Chengdu people, who have been drinking since childhood, suddenly lost their "backbone"? On the evening of September 8, Jule Co., Ltd. issued an announcement saying that Chairman Tong Enwen left on the afternoon of the 6th at the age of 78. The official website immediately changed to black and white, and even the road in Chengdu named after "Jule" seemed to have a bit of a heavy feeling.
What everyone cares most is "who will guard the country". You should know that Tong Enwen is not an ordinary boss. He holds 73.35% of Jule's voting rights in his hand. It is no exaggeration to say that he is the helmsman who is "speaking the truth". However, there was a foreshadowing. At the end of July, it was announced that Tong Enwen was in poor health and asked director Gao Chaohui to temporarily act as chairman. Gao Chaohui was his son-in-law and had been in charge of daily operations for many years as the general manager. Anyone with a discerning eye can see that this wave of handover was arranged early and very stable.
Speaking of Tong Enwen, this person is really a bit legendary. He spent his whole life in a "factory", from entering Chengdu Chemical Pharmaceutical Factory in 1966, to creating the "Jule" brand in 1984, and then in 1996, he first created sterile filling pure milk in the southwest, and dragging the factory from pharmaceuticals into the dairy industry, "Sora Milk" has been popular for decades. What's even more amazing is that the "stevia glycoside extraction process" he created in 1982 also received a reward from the Ministry of Light Industry, which even had special allowances from the State Council. No wonder he could achieve an annual revenue of 1.6 billion yuan and a net profit of over 200 million yuan.
And he is different from other bosses, and employees give him a thumbs up when they mention it. On the afternoon of the 8th, many retired employees came to mourn the Chengdu headquarters of Jule spontaneously. Some people said three of them were "very good" and said that he was particularly considerate of the employees. You can tell from the prospectus that by the end of 2024, among the more than 1,700 employees of Jule, there are more than 200 of them over 50 years old, and 12 of them re-employed after retirement, 95% have social security provident fund. New employees have not completed the job, but have just joined the company. This kind of humanity is rare in enterprises.
Now that the son-in-law Gao Chaohui takes over, the pressure is quite high. He has a very impressive resume and has been consulted at IBM and Boston. He joined Jule in 2011. His salary in 2024 is more than 5.34 million yuan, which is higher than Tong Enwen. It can be seen that he has been entrusted with important tasks for a long time. But the general environment of the dairy industry is not good now, and sales in the entire industry are declining. On the one hand, the national leader is under pressure, while the new dairy industry in the same city is also eyeing it. Jule can achieve revenue of 823 million yuan and a 6% increase in the first half of the year, which is already a good result. More importantly, Jule just submitted an IPO application for the Beijing Stock Exchange, and it was just a short time to go public. Whether it could be successfully listed, and how to stabilize the Sichuan market and even expand outward depends on Gao Zhaohui's ability.
In fact, Tong Enwen has long engraved "chrysanthemum music" into his bones in his life. From crossing the pharmaceutical industry to dairy industry, it depends on vision; to achieve an annual revenue of 1.6 billion yuan in a local factory, it depends on down-to-earth; employees think of him well because of sincerity. Now he has left, but what he has left is not only a 1.6 billion company, but also a kind of energy to "do one thing to the end".
Do you think Gao Zhaohui can take over this family business? How can a local dairy company like Jule, which has been rooted in the fierce competition in the future? Welcome to talk about your views in the comment section~
